Sheel Biotech Limited
✓Strengths
- Low debt: debt-to-equity of 0.32.
- Comfortable interest cover: operating profit covers interest about 8 times.
- Return on equity is moderate at 14%.
- Return on capital employed is healthy at 15.7%.
- Net profit margin is 10.9%.
- Profit has compounded about 20% a year over five years.
- Sales have compounded about 12% a year over five years.
- Has paid a dividend in 4 of the last 5 years.
- Promoters hold a majority stake (72.29%).
!Watch-points
- Recent profit growth (13%) is slower than the five-year pace (20%).
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreGrey zone
2.95
This middle range was less conclusive in Altman’s study — neither clearly safe nor clearly distressed.
Computed without the working-capital term (current-asset split not available for this stock).
Piotroski F-ScoreModerate
5 / 7
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 7 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap₹ 124 Cr
Current Price—
High / Low₹ 95.60 / 37.80
Stock P/E10.60
Book Value—
Dividend Yield0.00%
ROCE15.70%
ROE14.00%
Face Value₹ 10.00
Debt to Equity0.32
PEG Ratio0.33
EV / EBITDA8.88
Industry PE15.20
P/B Ratio—
EPS₹ 5.78
Debt₹ 27 Cr
PAT Margin10.91%
Cash PAT₹ 13 Cr
ICR8.00
Promoter Holding72.29%
FII Holding—
DII Holding9.49%
Public Holding18.22%
Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity